Key Takeaways
- Super Micro Computer stock jumped more than 17% following fiscal Q3 2026 results, with non-GAAP EPS of $0.84 crushing the $0.63 estimate by approximately 33%
- Revenue disappointed significantly at $10.24B versus the $12.39B consensus — a 17% miss
- Gross margins improved dramatically to 10.1% from the previous quarter’s 6.4%, though Q4 outlook suggests a retreat to 8.2%–8.4%
- Operating cash flow swung sharply negative to $6.6 billion, while net debt climbed to $7.5 billion
- Wall Street analysts remain cautious with a “Hold” consensus and average price target of $38.43, as legal troubles and regulatory investigations persist
Super Micro Computer (SMCI) shares began trading Friday at $33.46, giving the company a $20.12 billion market valuation. The stock experienced a substantial rally exceeding 17% after reporting its third fiscal quarter 2026 earnings — though beneath the surface, significant concerns remain.
Super Micro Computer, Inc., SMCI
Quarterly revenue reached $10.24 billion, representing a 122.7% year-over-year increase yet falling considerably below Wall Street’s $12.39 billion projection. Conversely, earnings per share hit $0.84, comfortably exceeding the $0.63 consensus forecast by roughly 33%.
The quarter’s defining narrative centers on profitability metrics. Gross margin staged an impressive recovery to 10.1%, bouncing back from a worrying 6.4% in the preceding period. This margin expansion stemmed primarily from an evolving revenue composition — AI GPU systems now account for more than 80% of total sales, delivering superior profitability.
However, this margin strength may prove temporary. Fourth quarter projections anticipate EPS between $0.65–$0.79, with margins expected to compress back toward 8.2%–8.4% as cost headwinds resurface.
Deteriorating Cash Position Raises Alarms
The financial statement that deserves closest scrutiny is the balance sheet. Operating cash flow experienced a dramatic reversal, plummeting to negative $6.6 billion. Inventory levels have swelled to $11.1 billion, while net debt has escalated to $7.5 billion.
Working capital requirements are intensifying rapidly as the business expands to fulfill AI infrastructure demand. This magnitude of cash consumption creates anxiety among investors, despite the compelling revenue growth narrative.
Management is projecting long-term revenue expansion from $40 billion climbing toward $60 billion by fiscal 2028, with annualized production capacity targets exceeding $100 billion. The forward price-to-earnings ratio stands at approximately 12.9x — attractively valued relative to technology sector peers, though this discount reflects substantial underlying risks.
Customer concentration metrics have shown improvement, declining from 63% to 27%. Enterprise channel revenue expanded 45% quarter-over-quarter — representing one of the report’s most encouraging metrics.
Ongoing Legal and Regulatory Headwinds
SMCI’s legal environment remains complicated. An active Department of Justice investigation continues. Several securities class action lawsuits feature lead-plaintiff deadlines concentrated around May 25–26. A recent complaint filed by Hagens Berman claims the company distributed AI servers containing export-restricted Nvidia chips to Chinese buyers through a shell company operating in Southeast Asia.
Taiwanese regulatory bodies are also reportedly pursuing detentions related to a separate smuggling investigation. These aren’t peripheral concerns — they’re actively constraining the stock’s valuation multiple despite favorable AI sector dynamics.
Regarding executive changes, SMCI brought on Vik Malyala as Chief Business Officer on May 11 and appointed Matthew Thauberger as Chief Revenue Officer on May 14, following Don Clegg’s retirement from his longstanding sales leadership role.
Institutional investors hold 84% of outstanding shares. North Dakota State Investment Board established a new stake during Q4, acquiring 17,620 shares worth approximately $516,000.
Wall Street price targets shifted following the earnings release: Northland elevated its objective from $22 to $34, JPMorgan raised its target from $28 to $32 while maintaining a “neutral” stance, and Wedbush reduced its price target from $42 to $34, also rated neutral. The Street consensus target sits at $38.43, with analyst recommendations split across four Buy ratings, eleven Hold ratings, and two Sell ratings.





